On the Use and Misuse of Genomic and Neuroimaging Science in Forensic Psychiatry: Current Roles and Future Directions

Child and Adolescent Psychiatric Clinics of North America

Volumn 20, Issue 3, 2011, Pages 533-546

  Treadway, Michael T ^a   Buckholtz, Joshua W ^a,b,c  

^a VANDERBILT UNIVERSITY   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c HARVARD UNIVERSITY   (United States)

Author keywords

Forensic assessment; Genetics; Law; Legally relevant psychopathology; MAOA; Neuroimaging

Indexed keywords

BEHAVIOR; FORENSIC GENETICS; FORENSIC NEUROIMAGING; FORENSIC NEUROSCIENCE; FORENSIC PSYCHIATRY; GENOMICS; HUMAN; LAW; LEGAL ASPECT; LEGAL EVIDENCE; MEDICAL ETHICS; NEUROBIOLOGY; NEUROIMAGING; PRIORITY JOURNAL; REVIEW; SOCIAL ASPECT;

BRAIN; DIAGNOSTIC IMAGING; DNA FINGERPRINTING; EXPERT TESTIMONY; FORECASTING; FORENSIC PSYCHIATRY; HUMANS; MENTAL COMPETENCY; MENTAL DISORDERS; PREDICTIVE VALUE OF TESTS; UNITED STATES;

EID: 79959265946     PISSN: 10564993     EISSN: 15580490     Source Type: Journal    
DOI: 10.1016/j.chc.2011.03.012     Document Type: Review

References (45)

1. McCabe D.P., Castel A.D. Seeing is believing: the effect of brain images on judgments of scientific reasoning. Cognition 2008, 107(1):343-352.
2. Weisberg D.S., Keil F.C., Goodstein J., et al. The seductive allure of neuroscience explanations. J Cogn Neurosci 2008, 20(3):470-477.
3. Moffitt T.E. Genetic and environmental influences on antisocial behaviors: evidence from behavioral-genetic research. Adv Genet 2005, 55:41-104.
4. Meyer-Lindenberg A., Weinberger D.R. Intermediate phenotypes and genetic mechanisms of psychiatric disorders. Nat Rev Neurosci 2006, 7(10):818-827.
5. Burmeister M., McInnis M.G., Zollner S. Psychiatric genetics: progress amid controversy. Nat Rev Genet 2008, 9(7):527-540.
6. Shih J.C., Chen K., Ridd M.J. Monoamine oxidase: from genes to behavior. Annu Rev Neurosci 1999, 22:197-217.
7. Brunner H.G., Nelen M.R., van Zandvoort P., et al. X-linked borderline mental retardation with prominent behavioral disturbance: phenotype, genetic localization, and evidence for disturbed monoamine metabolism. Am J Hum Genet 1993, 52(6):1032-1039.
8. Abeling N.G., van Gennip A.H., van Cruchten A.G., et al. Monoamine oxidase A deficiency: biogenic amine metabolites in random urine samples. J Neural Transm Suppl 1998, 52:9-15.
9. Brunner H.G., Nelen M., Breakefield X.O., et al. Abnormal behavior associated with a point mutation in the structural gene for monoamine oxidase A. Science 1993, 262(5133):578-580.
10. Sabol S.Z., Hu S., Hamer D. A functional polymorphism in the monoamine oxidase A gene promoter. Hum Genet 1998, 103(3):273-279.
11. Deckert J., Catalano M., Syagailo Y.V., et al. Excess of high activity monoamine oxidase A gene promoter alleles in female patients with panic disorder. Hum Mol Genet 1999, 8(4):621-624.
12. Fowler J.S., Alia-Klein N., Kriplani A., et al. Evidence that brain MAO A activity does not correspond to MAO A genotype in healthy male subjects. Biol Psychiatry 2007, 62(4):355-358.
13. Buckholtz J.W., Meyer-Lindenberg A. MAOA and the neurogenetic architecture of human aggression. Trends Neurosci 2008, 31(3):120-129.
14. Buckholtz J.W., Meyer-Lindenberg A. Gene-brain associations: the example of MAOA. Persistent violent offenders: neuroscience and rehabilitation 2009, 265-285. Oxford University Press, Oxford (United Kingdom). S. Hodgins, E. Viding (Eds.).
15. Caspi A., McClay J., Moffitt T.E., et al. Role of genotype in the cycle of violence in maltreated children. Science 2002, 297(5582):851-854.
16. Kim-Cohen J., Caspi A., Taylor A., et al. MAOA, maltreatment, and gene-environment interaction predicting children's mental health: new evidence and a meta-analysis. Mol Psychiatry 2006, 11(10):903-913.
17. Dodge K.A. Mechanisms of gene-environment interaction effects in the development of conduct disorder. Perspect Psychol Sci 2009, 4(4):408-414.
18. Nicodemus K.K., Law A.J., Radulescu E., et al. Biological validation of increased schizophrenia risk with NRG1, ERBB4, and AKT1 epistasis via functional neuroimaging in healthy controls. Arch Gen Psychiatry 2010, 67(10):991-1001.
19. Nicodemus K.K., Callicott J.H., Higier R.G., et al. Evidence of statistical epistasis between DISC1, CIT and NDEL1 impacting risk for schizophrenia: biological validation with functional neuroimaging. Arch Gen Psychiatry 2010, 67(10):991-1001.
20. Pezawas L., Meyer-Lindenberg A., Goldman A.L., et al. Evidence of biologic epistasis between BDNF and SLC6A4 and implications for depression. Mol Psychiatry 2008, 13(7):709-716.
21. Davatzikos C., Ruparel K., Fan Y., et al. Classifying spatial patterns of brain activity with machine learning methods: application to lie detection. Neuroimage 2005, 28(3):663-668.
22. Langleben D.D., Schroeder L., Maldjian J.A., et al. Brain activity during simulated deception: an event-related functional magnetic resonance study. Neuroimage 2002, 15(3):727-732.
23. Kozel F.A., Revell L.J., Lorberbaum J.P., et al. A pilot study of functional magnetic resonance imaging brain correlates of deception in healthy young men. J Neuropsychiatry Clin Neurosci 2004, 16(3):295-305.
24. Kozel F.A., Padgett T.M., George M.S. A replication study of the neural correlates of deception. Behav Neurosci 2004, 118(4):852-856.
25. Brown T., Murphy E. Through a scanner darkly: functional neuroimaging as evidence of mens rea. Stanford Law Rev 2010, 62:1119-1208.
26. Singh I., Rose N. Biomarkers in psychiatry. Nature 2009, 460(7252):202-207.
27. Poldrack R.A., Mumford J.A. Independence in ROI analysis: where is the voodoo?. Soc Cogn Affect Neurosci 2009, 4(2):208-213.
28. Perry J.E., Churchill L.R., Kirshner H.S. The Terri Schiavo case: legal, ethical, and medical perspectives. Ann Intern Med 2005, 143(10):744-748.
29. Leonard C.M., Towler S., Welcome S., et al. Paracingulate asymmetry in anterior and midcingulate cortex: sex differences and the effect of measurement technique. Brain Struct Funct 2009, 213(6):553-569.
30. Fornito A., Wood S.J., Whittle S., et al. Variability of the paracingulate sulcus and morphometry of the medial frontal cortex: associations with cortical thickness, surface area, volume, and sulcal depth. Hum Brain Mapp 2008, 29(2):222-236.
31. Huettel S.A., Song A.W., McCarthy G. Functional magnetic resonance imaging 2008, Sinauer Associates, Inc, Sunderland (United Kingdom). 2nd edition.
32. Lieberman M.D., Cunningham W.A. Type I and Type II error concerns in fMRI research: re-balancing the scale. Soc Cogn Affect Neurosci 2009, 4(4):423-428.
33. Logothetis N.K. What we can do and what we cannot do with fMRI. Nature 2008, 453(7197):869-878.
34. Tanabe J., Tregellas J.R., Dalwani M., et al. Medial orbitofrontal cortex gray matter is reduced in abstinent substance-dependent individuals. Biol Psychiatry 2009, 65(2):160-164.
35. Pizzagalli D.A., Holmes A.J., Dillon D.G., et al. Reduced caudate and nucleus accumbens response to rewards in unmedicated individuals with major depressive disorder. Am J Psychiatry 2009, 166(6):702-710.
36. Smoski M.J., Felder J., Bizzell J., et al. fMRI of alterations in reward selection, anticipation, and feedback in major depressive disorder. J Affect Disord 2009, 118:69-78.
37. Koch K., Wagner G., Schultz C., et al. Altered error-related activity in patients with schizophrenia. Neuropsychologia 2009, 47(13):2843-2849.
38. Wagner G., Sinsel E., Sobanski T., et al. Cortical inefficiency in patients with unipolar depression: an event-related FMRI study with the Stroop task. Biol Psychiatry 2006, 59(10):958-965.
39. Callicott J.H., Mattay V.S., Verchinski B.A., et al. Complexity of prefrontal cortical dysfunction in schizophrenia: more than up or down. Am J Psychiatry 2003, 160(12):2209-2215.
40. Sun D., van Erp T.G., Thompson P.M., et al. Elucidating a magnetic resonance imaging-based neuroanatomic biomarker for psychosis: classification analysis using probabilistic brain atlas and machine learning algorithms. Biol Psychiatry 2009, 66(11):1055-1060.
41. Koutsouleris N., Meisenzahl E.M., Davatzikos C., et al. Use of neuroanatomical pattern classification to identify subjects in at-risk mental states of psychosis and predict disease transition. Arch Gen Psychiatry 2009, 66(7):700-712.
42. Davatzikos C., Bhatt P., Shaw L.M., et al. Prediction of MCI to AD conversion, via MRI, CSF biomarkers, and pattern classification. Neurobiol Aging Jun 29 2010, [Epub ahead of print].
43. Arribas J., Calhoun V., Adali T. Automatic Bayesian classification of healthy controls, bipolar disorder and schizophrenia using intrinsic connectivity maps from fMRI data. IEEE Trans Biomed Eng 2010, 57:2850-2860.
44. Yang H., Liu J., Sui J., et al. A hybrid machine learning method for fusing fMRI and genetic data: combining both improves classification of schizophrenia. Front Hum Neurosci 2010, 4:192.
45. Maroney T.A. The false promise of adolescent brain science in juvenile justice. Notre Dame Law Rev 2010, 85:89.